Financials

  • Market Capitalization 9.05 B
  • Employee 315
  • Founded 2018
  • CEO N/A
  • Website www.immunovant.com
  • Headquarter Delaware, United States
  • FIGI BBG00P5MC0Q8
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-8.97
売上高対価格比率

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
943
PTGX
Protagonist Therapeutics, Inc. - Common Stock
149.50 USD-1.32%-1.36%+9.20%+98.99%9.67 B USD
981
PCVX
Vaxcyte, Inc. - Common Stock
61.16 USD+0.11%-1.12%+12.22%+44.59%9.10 B USD
992
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
84.85 USD+0.01%+0.18%+1.14%+106.45%9.00 B USD
993
ABVX
Abivax SA - American Depositary Shares
114.30 USD-1.91%-2.88%-8.49%+39.39%8.98 B USD

ニュース